Neutral/Negative Catalysts
- Sharp one-day drawdown (-14.28%) indicates a decisive repricing and increases odds of further technical weakness.
- Profitability still worsening YoY: net loss deeper and EPS more negative.
- R&D spend jumped (IP acquisitions/consulting for Plato), keeping operating losses elevated.
- Insider activity: insiders are selling, with selling amount up ~3008% over the last month → negative signal.
- Q4 FY2026 revenue guide ($5.7M–$6.5M) implies no clear acceleration from Q3 levels, limiting immediate upside narrative.